Related Experiment Video
Updated: Oct 9, 2026

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Factors influencing the reinforcing and subjective effects of d-amphetamine in humans
1Drug Abuse Research Center, Department of Psychiatry, MC3077, The Pritzker School of Medicine, The University of Chicago, 5841 S. Maryland Ave, Chicago, IL 60637, USA.
Abstract:
The reinforcing and subjective effects of oral d-amphetamine (AMP) were studied in a group of non-drug abusing adults (16 males, 13 females). A discrete-trial choice procedure was used to assess the reinforcing effects of a single dose of AMP (range 7.5-20mg across subjects). A number of factors (gender, current and past drug use, personality, motor activity, and baseline mood state and psychophysiological and sensory indices of arousal) were examined in an attempt to explain both within- and between-subject variability in response to AMP. Of the 29 subjects, 11 chose AMP on either two or three out of a possible three occasions. Cigarette smokers reported stronger aversive responses to AMP and chose the drug significantly less often than non-smokers. Subjects with a history of non-medical stimulant use reported less subjective response to AMP than subjects without such history. Within-subject variability in AMP choice was related to variability in subjective response to the drug across choice trials, as well as to variability in baseline mood: AMP was more likely to be chosen when subjects were more aroused and in a more positive mood at the time of the choice. These results provide new information regarding factors that may be relevant in determining individual differences in vulnerability to abuse of psychomotor stimulants.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

